5,691
Views
20
CrossRef citations to date
0
Altmetric
Review

Substance Use in Pregnancy: Identifying Stigma and Improving Care

, , , &
Pages 105-121 | Published online: 23 Nov 2021

References

  • Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24. doi:10.1016/S0277-9536(02)00304-0
  • McGinty EE, Barry CL. Stigma reduction to combat the addiction crisis - developing an evidence base. N Engl J Med. 2020;382(14):1291–1292. doi:10.1056/NEJMp2000227
  • Yanos PT, Lucksted A, Drapalski AL, Roe D, Lysaker P. Interventions targeting mental health self-stigma: a review and comparison. Psychiatr Rehabil J. 2015;38(2):171–178. doi:10.1037/prj0000100
  • Cunningham JA, Sobell LC, Chow VM. What’s in a label? The effects of substance types and labels on treatment considerations and stigma. J Stud Alcohol. 1993;54(6):693–699. doi:10.15288/jsa.1993.54.693
  • Cleveland LM, Bonugli RJ, McGlothen KS. The mothering experiences of women with substance use disorders. ANS Adv Nurs Sci. 2016;39(2):119–129. doi:10.1097/ANS.0000000000000118
  • Kennedy-Hendricks A, Busch SH, McGinty EE, et al. Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016;165:61–70. doi:10.1016/j.drugalcdep.2016.05.010
  • Stangl AL, Earnshaw VA, Logie CH, et al. The health stigma and discrimination framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17(1):31. doi:10.1186/s12916-019-1271-3
  • Stringer KL, Baker EH. Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues. 2018;39(1):3–27. doi:10.1177/0192513X15581659
  • Covington SS. Helping women recover: a comprehensive integrated treatment model. Alcohol Treat Quart. 2000;18(3):99–111. doi:10.1300/J020v18n03_09
  • Paeralta RL, Jauk D. A brief feminist review and critique of the sociology of alcohol-use and substance-abuse treatment approaches. Sociol Compass. 2011;5:882–897. doi:10.1111/j.1751-9020.2011.00414.x
  • Linnemann T. Mad men, meth moms, moral panic: gendering meth crimes in the Midwest. Crit Criminol. 2009;18:95–110. doi:10.1007/s10612-009-9094-8
  • Stone R. Pregnant women and substance use: fear, stigma, and barriers to care. Health Justice. 2015;3:2. doi:10.1186/s40352-015-0015-5
  • Worrall A. Women and Punishment: The Struggle for Justice. Willan Pub.; 2002.
  • Crenshaw K. Demarginalizing the Intersection of Race and Sex: A Black Feminist Critique of Antidiscimination Doctrine, Feminist Theory and Antiracist Politics. University of Chicago Legal Forum; 1989.
  • Saitz R, Miller SC, Fiellin DA, Rosenthal RN. Recommended use of terminology in addiction medicine. J Addict Med. 2021;15(1):3–7. doi:10.1097/ADM.0000000000000673
  • Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–207. doi:10.1016/j.drugpo.2009.10.010
  • Kelly JF, Westerhoff C, Westerhoff C. Does our choice of substance-related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. J Drug Issues. 2010;40:805–818. doi:10.1177/002204261004000403
  • National survey on drug use and health 2019; 2020. Available from: https://datafiles.samhsa.gov/. Accessed July 14, 2021.
  • Sherman E. Nixon’s Drug War, an Excuse to Lock Up Blacks and Protestors, Continues. Forbes; 2016.
  • Mitchell MM, Severtson SG, Latimer WW. Pregnancy and race/ethnicity as predictors of motivation for drug treatment. Am J Drug Alcohol Abuse. 2008;34(4):397–404. doi:10.1080/00952990802082172
  • Committee WHOGR. Guidelines for Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. ISBN: 9789241548731. World Health Organization; 2014.
  • Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.
  • American College of Obstetricians and Gynecologists ASoAM. Opioid Use and Opioid Use Disorder in Pregnancy. American College of Obstetricians and Gynecologists ASoAM; 2017.
  • American Psychiatric Association. American Psychiatric Association Position Statement: Assuring the Appropriate Care of Pregnant and Newly-Delivered Women with Substance Use Disorders. American Psychiatric Association; 2016.
  • Curry SJ, Krist AH, Owens DK, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US preventive services task force recommendation statement. JAMA. 2018;320(18):1899–1909. doi:10.1001/jama.2018.16789
  • Krist AH, Davidson KW, Mangione CM, et al. Screening for unhealthy drug use: US preventive services task force recommendation statement. JAMA. 2020;323(22):2301–2309. doi:10.1001/jama.2020.8020
  • Krist AH, Davidson KW, Mangione CM, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement. JAMA. 2021;325(3):265–279. doi:10.1001/jama.2020.25019
  • American Society of Addiction Medicine. Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids. American Society of Addiction Medicine; 2017.
  • American College of Obstetricians and Gynecologists. Substance Use Disorder in Pregnancy. Available from: https://www.acog.org/advocacy/policy-priorities/substance-use-disorder-in-pregnancy. Accessed November 10, 2021.
  • Patnode C, Perdue LA, Rushkin M, O’Connor EA. Screening for Unhealthy Drug Use in Primary Care in Adolescents and Adults, Including Pregnant Persons: Updated Systematic Review for the U.S. Preventative Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2020.
  • Toquinto SM, Berglas NF, McLemore MR, Delgado A, Roberts SCM. Pregnant women’s acceptability of alcohol, tobacco, and drug use screening and willingness to disclose use in prenatal care. Womens Health Issues. 2020;30(5):345–352. doi:10.1016/j.whi.2020.05.004
  • Day CC, Degenhardt L, Maher L, Maher L, Maher L. Reliability of heroin users’ reports of drug use behaviour using a 24 month timeline follow-back technique to assess the impact of the Australian heroin shortage. Addict Res Theory. 2004;12(5):433–443. doi:10.1080/16066350410001713231
  • Jackson CTC, Frisman LK, Essock SM, Essock SM. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. J Dual Diagn. 2005;1(1):49–63. doi:10.1300/J374v01n01_05
  • (NIDA) NIoDA. Resource guide: screening for drug use in general medical settings. 2012.
  • Chang G, Orav EJ, Jones JA, Buynitsky T, Gonzalez S, Wilkins-Haug L. Self-reported alcohol and drug use in pregnant young women: a pilot study of associated factors and identification. J Addict Med. 2011;5(3):221–226. doi:10.1097/ADM.0b013e318214360b
  • Chasnoff IJ, Wells AM, McGourty RF, Bailey LK. Validation of the 4P’s Plus screen for substance use in pregnancy validation of the 4P’s Plus. J Perinatol. 2007;27(12):744–748. doi:10.1038/sj.jp.7211823
  • Ondersma SJ, Chang G, Blake-Lamb T, et al. Accuracy of five self-report screening instruments for substance use in pregnancy. Addiction. 2019;114(9):1683–1693. doi:10.1111/add.14651
  • Ondersma SJ, Svikis DS, LeBreton JM, et al. Development and preliminary validation of an indirect screener for drug use in the perinatal period. Addiction. 2012;107(12):2099–2106. doi:10.1111/j.1360-0443.2012.03982.x
  • Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363–371. doi:10.1016/0306-4603(82)90005-3
  • Yonkers KA, Gotman N, Kershaw T, Forray A, Howell HB, Rounsaville BJ. Screening for prenatal substance use: development of the substance use risk profile-pregnancy scale. Obstet Gynecol. 2010;116(4):827–833. doi:10.1097/AOG.0b013e3181ed8290
  • Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busardo FP. Testing unconventional matrices to monitor for prenatal exposure to heroin, cocaine, amphetamines, synthetic cathinones, and synthetic opioids. Ther Drug Monit. 2020;42(2):205–221. doi:10.1097/FTD.0000000000000719
  • Roberts SC, Zahnd E, Sufrin C, Armstrong MA. Does adopting a prenatal substance use protocol reduce racial disparities in CPS reporting related to maternal drug use? A California case study. J Perinatol. 2015;35(2):146–150. doi:10.1038/jp.2014.168
  • Patel E, Bandara S, Saloner B, et al. Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016–2018. Am J Obstet Gynecol MFM. 2021;3(5):100419. doi:10.1016/j.ajogmf.2021.100419
  • Oni HT, Buultjens M, Abdel-Latif ME, Islam MM. Barriers to screening pregnant women for alcohol or other drugs: a narrative synthesis. Women Birth. 2019;32(6):479–486. doi:10.1016/j.wombi.2018.11.009
  • Institute G. Substance use during pregnancy. State laws and policies web site; 2021. Available from: https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy. Accessed September 8, 2021.
  • Perritt J. #WhiteCoatsForBlackLives - addressing physicians’ complicity in criminalizing communities. N Engl J Med. 2020;383(19):1804–1806. doi:10.1056/NEJMp2023305
  • Haffajee RL, Faherty LJ, Zivin K. Pregnant women with substance use disorders - the harm associated with punitive approaches. N Engl J Med. 2021;384(25):2364–2367. doi:10.1056/NEJMp2101051
  • Faherty LJ, Kranz AM, Russell-Fritch J, Patrick SW, Cantor J, Stein BD. Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome. JAMA Netw Open. 2019;2(11):e1914078. doi:10.1001/jamanetworkopen.2019.14078
  • Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202–207. doi:10.15585/mmwr.mm7006a4
  • Wallace B, van Roode T, Pagan F, et al. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduct J. 2020;17(1):29. doi:10.1186/s12954-020-00373-4
  • Slade H. Drug decriminalisation in Portugal: setting the record straight. 2020.
  • Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–1165. doi:10.1097/ALN.0000000000000472
  • Villapiano NL, Winkelman TN, Kozhimannil KB, Davis MM, Patrick SW. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pediatr. 2017;171(2):194–196. doi:10.1001/jamapediatrics.2016.3750
  • Ladhani NN, Shah PS, Murphy KE; Knowledge Synthesis Group on Determinants of Preterm LBWB. Prenatal amphetamine exposure and birth outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205(3):219 e211–217. doi:10.1016/j.ajog.2011.04.016
  • Press OU. Oxford English Dictionary. Third ed. Oxford University Press; 2021.
  • Nelson LF, Yocum VK, Patel KD, Qeadan F, Hsi A, Weitzen S. Cognitive outcomes of young children after prenatal exposure to medications for opioid use disorder: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(3):e201195. doi:10.1001/jamanetworkopen.2020.1195
  • National Harm Reduction Coalition AoPHR. Pregnancy and Substance Use: A Harm Reduction Toolkit. Health Research Board; 2020.
  • Lee SJ, Bora S, Austin NC, Westerman A, Henderson JMT. Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis. Acad Pediatr. 2020;20(3):308–318. doi:10.1016/j.acap.2019.11.005
  • Viteri OA, Soto EE, Bahado-Singh RO, Christensen CW, Chauhan SP, Sibai BM. Fetal anomalies and long-term effects associated with substance abuse in pregnancy: a literature review. Am J Perinatol. 2015;32(5):405–416.
  • Goldman-Mellor S, Margerison CE. Maternal drug-related death and suicide are leading causes of postpartum death in California. Am J Obstet Gynecol. 2019;221(5):489e481–489 e489. doi:10.1016/j.ajog.2019.05.045
  • Deaths BUSCTRaPM. Report from nine maternal mortality review committees. 2018.
  • Corrigan PW, Lara JL, Shah BB, Mitchell KT, Simmes D, Jones KL. The public stigma of birth mothers of children with fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2017;41(6):1166–1173. doi:10.1111/acer.13381
  • Wakeman S, Jordan A, Beletsky L. When Reimagining Systems Of Safety, Take A Closer Look At The Child Welfare System | Health Affairs Blog. Healthaffairs.org. Available from: https://www.healthaffairs.org/do/10.1377/hblog20201002.72121/full/. Accessed November 10, 2021.
  • Gynecologists ACoOa. Opposition to Criminalization of Individuals During Pregnancy and the Postpartum Period. Gynecologists ACoOa; 2020.
  • Harp KLH, Oser CB. A longitudinal analysis of the impact of child custody loss on drug use and crime among a sample of African American mothers. Child Abuse Negl. 2018;77:1–12. doi:10.1016/j.chiabu.2017.12.017
  • Angelotta C, Appelbaum PS. Criminal charges for child harm from substance use in pregnancy. J Am Acad Psychiatry Law. 2017;45(2):193–203.
  • Daniel R. Prisons neglect pregnant women in their healthcare policies. Prison policy initiative; 2019. Available from: prisonpolicy.org/blog/2019/12/05/pregnancy/. Accessed September 8, 2021.
  • Union ACL, Ferguson V. City of Charleston: social and legal contexts; 2021. Available from: https://www.aclu.org/other/ferguson-v-city-charleston-social-and-legal-contexts?redirect=reproductive-freedom/ferguson-v-city-charleston-social-and-legal-contexts. Accessed August 27, 2021.
  • Paltrow LM, Flavin J. Arrests of and forced interventions on pregnant women in the United States, 1973–2005: implications for women’s legal status and public health. J Health Polit Policy Law. 2013;38(2):299–343. doi:10.1215/03616878-1966324
  • International Amnesty. Criminalizing pregnancy: policing pregnant women who use drugs in the USA. Amnesty International; 2017. Available from: amnestyusa.org/reports/criminalizing-pregnancy-policing-pregnant-women-use-drugs-usa/. Accessed September 8, 2021.
  • Clarkson AF, Christian WM, Pearce ME, et al. The Cedar Project: negative health outcomes associated with involvement in the child welfare system among young Indigenous people who use injection and non-injection drugs in two Canadian cities. Can J Public Health. 2015;106(5):e265–270. doi:10.17269/cjph.106.5026
  • Salameh TN, Hall LA. Depression, anxiety, and substance use disorders and treatment receipt among pregnant women in the United States: a systematic review of trend and population-based studies. Issues Ment Health Nurs. 2020;41(1):7–23. doi:10.1080/01612840.2019.1667460
  • Phillippi JC, Schulte R, Bonnet K, et al. Reproductive-age women’s experience of accessing treatment for opioid use disorder: “we don’t do that here”. Womens Health Issues. 2021;31:455–461. doi:10.1016/j.whi.2021.03.010
  • Patrick SW, Richards MR, Dupont WD, et al. Association of pregnancy and insurance status with treatment access for opioid use disorder. JAMA Netw Open. 2020;3(8):e2013456. doi:10.1001/jamanetworkopen.2020.13456
  • El-Mohandes A, Herman AA, Nabil El-Khorazaty M, Katta PS, White D, Grylack L. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol. 2003;23(5):354–360. doi:10.1038/sj.jp.7210933
  • Niccols A, Milligan K, Smith A, Sword W, Thabane L, Henderson J. Integrated programs for mothers with substance abuse issues and their children: a systematic review of studies reporting on child outcomes. Child Abuse Negl. 2012;36(4):308–322. doi:10.1016/j.chiabu.2011.10.007
  • Ruger JP, Lazar CM. Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review. Addict Behav. 2012;37(1):1–10. doi:10.1016/j.addbeh.2011.07.042
  • Terplan M, Laird HJ, Hand DJ, et al. Opioid detoxification during pregnancy: a systematic review. Obstet Gynecol. 2018;131(5):803–814. doi:10.1097/AOG.0000000000002562
  • Medicine ASoA. National practice guideline for the use of medications in the treatment of addiction involving opioid use; 2018. Available from: https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf. Accessed September 10, 2021.
  • World Health Organization. Community management of opioid overdose; 2014. Available from: http://apps.who.int/iris/bitstream/10665/137462/1/9789241548816_eng.pdf. Accessed September 10, 2021.
  • Zedler BK, Mann AL, Kim MM, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115–2128. doi:10.1111/add.13462
  • Minozzi S, Amato L, Jahanfar S, Bellisario C, Ferri M, Davoli M. Maintenance agonist treatments for opiate-dependent pregnant women. Cochrane Database Syst Rev. 2020;11:CD006318.
  • Monnelly VJ, Hamilton R, Chappell FM, Mactier H, Boardman JP. Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis. Dev Med Child Neurol. 2019;61(7):750–760. doi:10.1111/dmcn.14117
  • Kelty E, Hulse G. A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls. Drugs. 2017;77(11):1199–1210. doi:10.1007/s40265-017-0762-9
  • Thibaut F, Chagraoui A, Buckley L, et al. WFSBP (*) and IAWMH (**) guidelines for the treatment of alcohol use disorders in pregnant women. World J Biol Psychiatry. 2019;20(1):17–50. doi:10.1080/15622975.2018.1510185
  • Patnode CD, Henderson JT, Coppola EL, Melnikow J, Durbin S, Thomas RG. Interventions for tobacco cessation in adults, including pregnant persons: updated evidence report and systematic review for the US preventive services task force. JAMA. 2021;325(3):280–298. doi:10.1001/jama.2020.23541
  • Chamberlain C, O’Mara-Eves A, Porter J, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev. 2017;2:CD001055.
  • Finlay AK, Harris AHS, Timko C, et al. Disparities in access to medications for opioid use disorder in the veterans health administration. J Addict Med. 2021;15(2):143–149. doi:10.1097/ADM.0000000000000719
  • Short VL, Hand DJ, MacAfee L, Abatemarco DJ, Terplan M. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States. J Subst Abuse Treat. 2018;89:67–74. doi:10.1016/j.jsat.2018.04.003
  • Renbarger KM, Shieh C, Moorman M, Latham-Mintus K, Draucker C. Health care encounters of pregnant and postpartum women with substance use disorders. West J Nurs Res. 2020;42(8):612–628. doi:10.1177/0193945919893372
  • Lagadec N, Steinecker M, Kapassi A, et al. Factors influencing the quality of life of pregnant women: a systematic review. BMC Pregnancy Childbirth. 2018;18(1):455. doi:10.1186/s12884-018-2087-4
  • Fergie L, Campbell KA, Coleman-Haynes T, Ussher M, Cooper S, Coleman T. Identifying effective behavior change techniques for alcohol and illicit substance use during pregnancy: a systematic review. Ann Behav Med. 2019;53(8):769–781. doi:10.1093/abm/kay085
  • Terplan M, Ramanadhan S, Locke A, Longinaker N, Lui S. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database Syst Rev. 2015;(4):CD006037. doi:10.1002/14651858.CD006037.pub3
  • Vedam S, Stoll K, Taiwo TK, et al. The giving voice to mothers study: inequity and mistreatment during pregnancy and childbirth in the United States. Reprod Health. 2019;16(1):77. doi:10.1186/s12978-019-0729-2
  • Charlet K, Heinz A. Harm reduction – a systematic review on effects of alcohol reduction on physical and mental symptoms. Addict Biol. 2017;22(5):1119–1159. doi:10.1111/adb.12414
  • Jones HE, O’Grady K, Dahne J, et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse. 2009;35(3):151–156. doi:10.1080/00952990902825413
  • MacVicar S, Kelly LE. Systematic mixed-study review of nonpharmacological management of neonatal abstinence syndrome. Birth. 2019;46(3):428–438. doi:10.1111/birt.12427
  • Wilder C, Lewis D, Winhusen T. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug Alcohol Depend. 2015;149:225–231. doi:10.1016/j.drugalcdep.2015.02.012
  • Feltner C, Weber RP, Stuebe A, Grodensky CA, Orr C, Viswanathan M. Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries. Rockville (MD): Agency for Healthcare Research and Quality; 2018.
  • Gynecologists ACoOa. Breastfeeding challenges. acog.org2021. 2021.
  • McQueen K, Taylor C, Murphy-Oikonen J. Systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs. 2019;48(4):398–407. doi:10.1016/j.jogn.2019.03.004
  • Gynecologists ACoOa. Marijuana use during pregnancy and lactation. Obstet Gynecol. 2017;130:e205–209. doi:10.1097/AOG.0000000000002354